Cargando…

High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors

Doublecortin-like kinase 1 (DCLK1), a microtubule-associated protein, is known to regulate neuronal differentiation, migration and neurogenesis. Recent evidence suggests that the protein is a putative marker for intestinal and pancreatic stem cells, including their cancer stem cell counterparts. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	IKEZONO, YU, KOGA, HIRONORI, ABE, MITSUHIKO, AKIBA, JUN, KAWAHARA, AKIHIKO, YOSHIDA, TAKAFUMI, NAKAMURA, TORU, IWAMOTO, HIDEKI, YANO, HIROHISA, KAGE, MASAYOSHI, SATA, MICHIO, TSURUTA, OSAMU, TORIMURA, TAKUJI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579808/ https://www.ncbi.nlm.nih.gov/pubmed/26622789 http://dx.doi.org/10.3892/ol.2015.3513

Ejemplares similares

STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury
por: Abe, Mitsuhiko, et al.
Publicado: (2017)

High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine
por: Wada, Fumitaka, et al.
Publicado: (2018)

Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma
por: Torimura, Takuji, et al.
Publicado: (2016)

Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces “angiogenic switch off” in a hepatoma mouse model
por: Iwamoto, Hideki, et al.
Publicado: (2015)

Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line
por: Hashimoto, Osamu, et al.
Publicado: (2006)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
por: Iwamoto, Hideki, et al.
Publicado: (2022)

Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis
por: Nakamura, Toru, et al.
Publicado: (2016)

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)
por: Nakano, Dan, et al.
Publicado: (2020)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
por: AKIBA, JUN, et al.
Publicado: (2014)

Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma
por: Shimose, Shigeo, et al.
Publicado: (2020)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease
por: Suzuki, Hiroyuki, et al.
Publicado: (2021)

Gastric Neuroendocrine Carcinoma with Rapid Progression
por: Iwamoto, Maho, et al.
Publicado: (2020)

Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
por: Torimura, Takuji, et al.
Publicado: (2021)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

Inhomogeneous distribution of Chlamydomonas in a cylindrical container with a bubble plume
por: Nonaka, Yuki, et al.
Publicado: (2016)

Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments
por: Suzuki, Hiroyuki, et al.
Publicado: (2021)

Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis
por: Nakano, Masahito, et al.
Publicado: (2020)

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound
por: Kamachi, Naoki, et al.
Publicado: (2021)

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma
por: Okamura, Shusuke, et al.
Publicado: (2022)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
por: Nakano, Dan, et al.
Publicado: (2022)

Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis
por: Arinaga-Hino, Teruko, et al.
Publicado: (2022)

Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy
por: Kawaguchi, Toshihiro, et al.
Publicado: (2019)

Pleiotropic effects of DCLK1 in cancer and cancer stem cells
por: Chhetri, Dibyashree, et al.
Publicado: (2022)

Mucoepidermoid carcinoma of the sublingual gland harboring a translocation of the MAML2 gene: A case report
por: Sato, Kiminobu, et al.
Publicado: (2017)

Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line
por: Ogasawara, Sachiko, et al.
Publicado: (2017)

Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer
por: Yasumoto, Makiko, et al.
Publicado: (2016)

Potential usefulness of mucin immunohistochemical staining of preoperative pancreatic biopsy or juice cytology specimens in the determination of treatment strategies for intraductal papillary mucinous neoplasm
por: HISAKA, TORU, et al.
Publicado: (2013)

A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection
por: Yasumoto, Makiko, et al.
Publicado: (2018)

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection
por: Sumie, Shuji, et al.
Publicado: (2011)

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
por: Galvan, Laurie, et al.
Publicado: (2018)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis
por: Carli, Annalisa L. E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1u1olkm10d2oavqd4lkrqqr610